Alcohol-Drug Interactions
Alcohol interacts with drugs through CNS depression, CYP2E1 modulation, acetaldehyde accumulation, and GI effects. Both acute and chronic alcohol use create distinct interaction patterns.
## Dual Nature of Alcohol Interactions
Alcohol affects drug metabolism in opposite directions depending on exposure pattern. Acute alcohol intake inhibits CYP2E1 and other enzymes, increasing drug levels. Chronic heavy drinking induces CYP2E1 and to some extent CYP3A4, accelerating drug clearance. This duality makes alcohol one of the most complex interacting substances.
## CNS Depression Synergy
Alcohol potentiates all CNS depressants through additive or synergistic GABAergic and glutamatergic effects:
- **Benzodiazepines** — the combination causes respiratory depression and is a leading cause of overdose death
- **Opioids** — synergistic respiratory depression; alcohol co-ingestion is present in a large fraction of opioid overdose deaths
- **Sedating antihistamines** (diphenhydramine, doxylamine) — impaired driving and falls
- **Muscle relaxants** (cyclobenzaprine, baclofen) — additive sedation
- **Gabapentinoids** — enhanced sedation and respiratory risk
Even "non-sedating" antihistamines (cetirizine) show mild CNS effects with alcohol.
## Metabolic Interactions
### Acute Alcohol
Single-episode drinking inhibits hepatic enzymes, increasing blood levels of:
- **Warfarin** — single binge can elevate INR unpredictably
- **Phenytoin** — acute alcohol increases phenytoin levels
- **Metformin** — increased lactate production; lactic acidosis risk elevated
### Chronic Alcohol
Daily heavy drinking induces CYP2E1, increasing metabolism of:
- **Acetaminophen** — CYP2E1 converts more acetaminophen to the toxic metabolite NAPQI; combined with glutathione depletion from malnutrition, even therapeutic doses can cause hepatotoxicity in chronic alcoholics
- **Isoniazid** — enhanced hepatotoxic metabolite formation
- **Warfarin** — chronic drinking may reduce warfarin effect through induction (opposite of acute effect)
## Disulfiram-Like Reactions
Certain drugs inhibit aldehyde dehydrogenase, causing acetaldehyde accumulation when alcohol is consumed. Symptoms include flushing, nausea, vomiting, tachycardia, and hypotension:
- **Disulfiram** — intentional therapeutic use for alcohol deterrence
- **Metronidazole** — traditionally taught as disulfiram-like; evidence is debated but caution is standard practice
- **Cephalosporins** with methyltetrazole side chain (cefotetan, cefoperazone) — documented disulfiram-like reactions
- **Griseofulvin** — case reports of flushing reactions with alcohol
## GI and Hepatotoxicity Interactions
- **NSAIDs + alcohol** — both damage gastric mucosa; combined use markedly increases GI bleeding risk. The FDA mandates alcohol warnings on OTC NSAID labels.
- **Acetaminophen + alcohol** — FDA requires warnings on all acetaminophen products. Maximum 2 g/day recommended for regular drinkers (vs. 4 g/day standard).
- **Methotrexate + alcohol** — additive hepatotoxicity; patients on methotrexate are counseled to minimize or avoid alcohol entirely.
## Dose-Dumping
Extended-release formulations (opioids, stimulants) may release their full dose at once when taken with alcohol, which disrupts the controlled-release matrix. The fentanyl patch and several ER opioid formulations carry specific warnings.
## Key Takeaways
- Acute alcohol inhibits drug metabolism; chronic alcohol induces CYP2E1
- Alcohol + any CNS depressant creates synergistic sedation and respiratory depression risk
- Chronic alcoholics are vulnerable to acetaminophen hepatotoxicity even at therapeutic doses
- NSAIDs + alcohol dramatically increases GI bleeding risk
- Extended-release drug formulations may dose-dump when taken with alcohol